Isolation, Characterization and Proliferation of Cancer Cells from Breast Cancer Patients
| Autor: | Dian Ratih Laksmitawati, Yusuf Heriady, Ahmad Faried, Mawar Subangkit, Fajar Sukma Perdana, Annisa Amalia, Zakiyatul Khoiriyah, Teresa Liliana Wargasetia, Annisa Arlisyah, Wahyu Widowati, Rizal Rizal, Diana Krisanti Jasaputra |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
CD24 antigen
0301 basic medicine Cell Estrogen receptor cell lines 03 medical and health sciences breast cancer 0302 clinical medicine Breast cancer Antigen Medicine skin and connective tissue diseases Original Paper biology business.industry CD24 CD44 General Medicine medicine.disease 030104 developmental biology medicine.anatomical_structure CD44 antigen 030220 oncology & carcinogenesis Cancer cell Cancer research biology.protein enzymatic assay business Breast carcinoma |
| Zdroj: | Acta Informatica Medica |
| ISSN: | 0353-8109 |
| Popis: | Introduction: The most cases of cancer death, which are in the first ranks among cancers suffered by women is breast cancer. The breast cancer therapy for patients has been done, but still not optimal, so it is necessary to understand the mechanism of therapy in model cell of breast cancer. Aim: This study aims to develop an isolation technique of breast cancer cell from patients as a cancer cell model. Material and Methods: Breast cancer cell isolation is performed by enzymatic methods using the collagen I and hyaluronidase. Then, breast cancer cells were characterized using flow cytometry based on the CD44/CD24 expression where MDA-MB468 and MCF-7 breast cancer cell lines were used as positive controls. Estrogen receptor (ER), progesterone receptor (PR), p53, HER2, and Ki67 expression were assessed using an immunohistochemistry assay. Result and Discussion: The morphology of cancer cells was fibroblast like cells on the day 7th after isolation. Isolated breast cancer cells expressed 95.33±0.47% of CD44+/CD24+ and human epidermal growth factor receptor 2 (HER2) low expressions. Isolation of breast cancer cells can use In-house enzymatic protocol. Isolated breast cancer showed the same expression as MDA-MB468 (CD44+/CD24+) and HER2- compared to MCF-7 cell lines (CD44-/CD24+). Conclusion: These cells belonged to a basal type of breast carcinoma and expressed CD44+/CD24+, then isolated BCCs can be used as model cancer cells for further research. Keywords: breast cancer, cell lines, CD44 antigen, CD24 antigen, enzymatic assay. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|